Heart Failure Flashcards

1
Q

Definitions of heart failure diagnostic categories

A

HFrEF - EF < 40%
HFpEF - EF > 50% (delayed HR recovery and less increase in CO with exercise)

Subcategories
HFpEF, borderline - EF 41-49%
HFpEF, improved - pts with HFpEF who previously had HFrEF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the New York Heart Association (NYHA) Classifications

A

I - no limitation
II - comfortable at rest, but ordinary physical activity results in symptoms
III - comfortable at rest, but less than ordinary activity causes symptoms
IV - unable to carry out any physical activity, or sxs at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is BNP related to CrCl?

A

BNP is renally excreted, so it is inversely proportional to Cr Clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do you interpret BNP levels?

What is the exception?

A

BNP < 100 excludes HF as cause of dyspnea
BNP > 400 confers 95% likelihood

*exception if BMI > 35 - upper normal is 50 as BNP is possibly cleared by adipocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Physio bases for HF treatment: Which meds do you use for the following?

Preload reduction

A

Diuretics, nitrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Physio bases for HF treatment: Which meds do you use for the following?

Afterload reduction

A

ACE/ARB, hydralazine, nitrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Physio bases for HF treatment: Which meds do you use for the following?

Sympathetic blockade

A

Beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Physio bases for HF treatment: Which meds do you use for the following?

Aldosterone antagonist therapy

A

spironolactone, eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:

ACE/ARB

A

Reduces morbidity and mortality

LOE A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:

Beta blocker

A

Mortality rates improve with BB in addition to ACEi and diuretics

Decrease mortality in pts with prior MI regardless of NYHA

Start when pt is stable and euvolemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which beta blockers are “the proven 3” in HF

A

Metoprolol succinate, carvedilol, bisoprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:

Aldosterone antagonists

A

reduce mortality and improve EF

  • GFR must be > 30 and K < 5
  • choices are spironolactone and eplerenone
  • eplerenon is better for breast tenderness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:

Furosemide

A

Improves symptoms and reduces hospitalizations

Class I recommendation, LOE C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:

BIDIL

A

Hydralazine + Isosorbide Dinitrate
Reduces mortality rates and improves quality of life measures
- particularly effective in african americans with NYHA III or IV HF
- used when diuretics, BB and ACE do not control sx or are not tolerated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

State whether this medication has morbidity and mortality benefit, symptom improvement, decreased hospitalizations in treatment of HF:

ARNI = ARB + Neprilysin Inhibitor

A

Compared to enalapril - reduced death and hospitalization
Class I recommendation: use in pts with chronic SYMPTOMATIC HFrEF NYHA II or III

  • wait 36 hours after stopping ACEi to start entresto
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which medications should you avoid in HFrEF?

A
  • CCB (may continue amlodipine)
  • Most antiarrhythmics
  • NSAIDs
  • Thiazolidinediones (- glitazones)
17
Q

Who should get an AICD?

A

Criteria to meet:

  • EF < 35%
  • NYHA II or III sx on medications
  • life expectancy > 1 year
18
Q

Who should get cardiac resynchronization therapy (CRT) (biventricular pacing)?

A

Criteria to meet:

  • EF < 35%
  • NYHA II, III, or IV sx on meds
  • QRS > 150 ms
  • life expectancy > 1 year
19
Q

What have studies shown about guidelines for BMI in HF

A
  • weight loss should only be encouraged in pts with BMI > 40

- survival is highest in pts with BMI 30-32

20
Q

What are the sodium and fluid restriction guidelines in HF

A
  • Sodium < 2400 mg daily

- fluid < 2L/day may be appropriate in pts with hyponatremia or persistent retention